HOME >> MEDICINE >> NEWS
Clinical trial of Etanercept for Wegener's disease shows no benefit

A Johns Hopkins-led study designed to evaluate the ability of etanercept to maintain disease remissions in a serious autoimmune disorder has failed to show any benefit. Etanercept, also called Enbrel, is a common treatment for rheumatoid arthritis and other types of joint inflammation.

"We had hoped that this approach to the treatment of Wegener's granulomatosis would be useful in preventing disease relapses," says John H. Stone, M.D., associate professor of medicine, director of the Johns Hopkins Vasculitis Center, and lead investigator of the study published in the Jan. 27, 2005, issue of the New England Journal of Medicine.

"The study results, however, demonstrate unequivocally that etanercept was not effective for this purpose. Because of the disease's propensity to flare following remission and the high risk of treatment complications associated with conventional therapies for Wegener's, we must continue to look for safe, effective ways of achieving and maintaining disease remissions," said Stone.

Wegener's granulomatosis is an uncommon disorder in which the body's immune system attacks its own blood vessels, damaging vital organs by limiting the flow of blood to lungs, kidneys, upper airways and other organs. The disease can affect people of any age and occurs in men and women with equal frequency.

Although current medications used to treat Wegener's halt the disease temporarily in most patients, 60 to 80 percent of patients eventually suffer from disease flares. The need to treat many patients repeatedly with medications such as glucocorticoids (prednisone), cyclophosphamide, and methotrexate leads to mounting morbidity from treatments. At the same time, each disease flare has the potential to cause irreversible damage. Wegener's granulomatosis frequently leads to kidney failure, hearing loss, damage to the respiratory tract, peripheral nerve injury, and other complications, according to Stone.

Etanercept, the f
'"/>

Contact: Trent Stockton
tstockt1@jhmi.edu
410-955-8665
Johns Hopkins Medical Institutions
26-Jan-2005


Page: 1 2 3

Related medicine news :

1. Clinical breast examination offers modest benefit to breast cancer screening program
2. Clinical trial participants fare no better, no worse than other patients
3. Clinical trial shows drug may offer a new option to prevent rejection of transplanted kidneys
4. National Academies news: Clinical research involving children
5. Clinical research key in advance to prospective health care
6. Clinical trial of new TB vaccine begins
7. Clinical trial of Alzheimers disease drug shows clear reductions in AD development
8. Clinical factors useful to identify heart failure patients with high risk of death
9. Panel: Clinical use of embryonic stem cells jeopardized by Bushs policy on federal funding
10. $7 million grant continues Asthma Clinical Research Network efforts
11. Clinical study of Penn State Hershey technology begins in South Africa

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... Tenn. (PRWEB) , ... October 10, 2019 , ... ... of management consulting and information technology (IT) services for the healthcare industry, has ... the Public Hospitals Authority (PHA) of the Commonwealth of The Bahamas towards a ...
(Date:10/8/2019)... ... October 08, 2019 , ... What unique insights can ... state of aging and wellness in the nation? That question will be answered at ... Conference, Leadership Summit and Expo. The event will take place October 10-12, 2019, at ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... for the Department of Veterans Affairs Community Care Referrals and Authorizations program. The ... the VA’s Health Share Referral Manager (HSRM), an enterprise-wide system used by community ...
(Date:10/8/2019)... ... ... Over the past three decades, Buffalo Wings & Rings has elevated the chicken wing ... higher-quality product and experience than the competition. Now, the club-level sports restaurant brand has ... THE CAUSE" campaign in support of Breast Cancer Awareness Month. , “We are ...
(Date:10/8/2019)... ... October 08, 2019 , ... The University of California San ... Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. ... promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital ...
Breaking Medicine News(10 mins):
(Date:10/22/2019)... , ... October 22, 2019 , ... ... the 2019 Excellency in Advocacy Award for Excellence in a State Issue Campaign ... initiative, SUNucate , and the contributions of ASDSA’s Advocacy team: Kristin Hellquist, ...
(Date:10/19/2019)... ... October 18, 2019 , ... Whealthcare Planning, the industry’s only ... growing momentum for the company and its technology, along and a corresponding capital ... wealthmanagement.com’s Industry Awards Program, Whealthcare Planning was recognized for Technology Thought Leadership for ...
(Date:10/19/2019)... ... ... Hospital M&A activity held steady with 21 transactions in both the second ... recent quarter was down 20% compared with the same period in 2018, when 25 ... nearly $5.0 billion, a 291% increase. Year over year, Q3:19 spending was down 41% ...
Breaking Medicine Technology:
Cached News: